1. Home
  2. GALT vs RYAM Comparison

GALT vs RYAM Comparison

Compare GALT & RYAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Galectin Therapeutics Inc.

GALT

Galectin Therapeutics Inc.

HOLD

Current Price

$3.49

Market Cap

397.3M

Sector

Health Care

ML Signal

HOLD

Logo Rayonier Advanced Materials Inc.

RYAM

Rayonier Advanced Materials Inc.

HOLD

Current Price

$6.67

Market Cap

438.3M

ML Signal

HOLD

Company Overview

Basic Information
Metric
GALT
RYAM
Founded
2000
1926
Country
United States
United States
Employees
N/A
2325
Industry
Biotechnology: Pharmaceutical Preparations
Paper
Sector
Health Care
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
397.3M
438.3M
IPO Year
2008
2014

Fundamental Metrics

Financial Performance
Metric
GALT
RYAM
Price
$3.49
$6.67
Analyst Decision
Analyst Count
0
0
Target Price
N/A
★ $14.00
AVG Volume (30 Days)
197.8K
★ 1.1M
Earning Date
11-13-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 36.84
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $1,466,397,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$2.70
P/E Ratio
★ N/A
N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$2.03
$5.38
52 Week High
$7.13
$11.85

Technical Indicators

Market Signals
Indicator
GALT
RYAM
Relative Strength Index (RSI) 45.36 35.98
Support Level $2.71 $6.55
Resistance Level $3.56 $8.81
Average True Range (ATR) 0.23 0.29
MACD -0.02 0.00
Stochastic Oscillator 41.34 28.26

Price Performance

Historical Comparison
GALT
RYAM

About GALT Galectin Therapeutics Inc.

Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.

About RYAM Rayonier Advanced Materials Inc.

Rayonier Advanced Materials Inc engaged in the production and sale of high-purity cellulose and other cellulose-based materials derived from renewable wood fiber. The company operates through five segments: Cellulose Specialties, which produces purified cellulose used in products such as filters, pharmaceuticals, food additives and electronics; Biomaterials, which produces products including biofuels, lignosulfonates and other bio-based chemicals; Cellulose Commodities, which manufactures absorbent and viscose pulp used in textiles and hygiene products; Paperboard, which produces coated paperboard used for packaging and printing applications; and High-Yield Pulp, which produces pulp used in paperboard, packaging and printing paper products.

Share on Social Networks: